Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nanomix (NNMX)
OTHER OTC:NNMX
Holding NNMX?
Track your performance easily
NNMX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.02 - $0.02
Previous Close$0.02
Volume12.00
Average Volume (3M)N/A
Market Cap
$4.90K
Enterprise Value$1.31M
Total Cash (Recent Filing)$17.11K
Total Debt (Recent Filing)$1.33M
Price to Earnings (P/E)―
Beta3.05
Next Earnings
May 17, 2022EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding48,996,763
10 Day Avg. Volume1
30 Day Avg. VolumeN/A
Standard Deviation9.96
R-Squared0.00495
Alpha1.19
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.32
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue85.04
Enterprise Value/Gross Profit85.04
Enterprise Value/Ebitda-0.16
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Nanomix News
Ownership Overview
87.23%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
12.77% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
NNMX FAQ
What was Nanomix’s price range in the past 12 months?
Nanomix lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Nanomix’s market cap?
Currently, no data Available
When is Nanomix’s upcoming earnings report date?
Nanomix’s upcoming earnings report date is May 17, 2022 which is 857 days ago.
How were Nanomix’s earnings last quarter?
Nanomix released its earnings results on Apr 16, 2019. The company reported -$0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.009.
Is Nanomix overvalued?
According to Wall Street analysts Nanomix’s price is currently Overvalued.
Does Nanomix pay dividends?
Nanomix does not currently pay dividends.
What is Nanomix’s EPS estimate?
Nanomix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nanomix have?
Nanomix has 48,996,760 shares outstanding.
What happened to Nanomix’s price movement after its last earnings report?
Nanomix reported an EPS of -$0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -14.65%.
Which hedge fund is a major shareholder of Nanomix?
Currently, no hedge funds are holding shares in NNMX
---
Company Description
Nanomix
Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products are designed to help manage blood sugar, treat pre-diabetes, and diabetes related pathologies. Its drug candidates comprises of BTI320, BTI-410, and IPOXYN. The company was founded by David Platt and Kenneth A. Tassey Jr. on August 24, 2009 and is headquartered in Lawrence, MA.
---
Technical Analysis
---